Bohui Bio set up an experimental team and a medical team last year (2065438+August), and went to Lian Jian Clinic to connect immune cell process and medical technology. Recently, it has completed the technology transfer, passed the Japanese examination and obtained the certification. Bohui Clinic is the first unit in the world to obtain the world patent technology transfer of Lian Jian's HITV immune cell therapy.
The effective rate of Lian Jian therapy is as high as 75%. Japanese Lian Jian therapy, also known as HITV therapy, was developed by Kenichiro Lian Jian in 2005. According to Kenichiro Lian Jian, Dendritic Cells (DC) in immune cells are trained as special forces with antigens on their own cancer cells, and then these skills of identifying cancer cells are passed on to T cells (CTL) with killing effect, so that these killer immune cells can quickly and accurately identify cancer cells in the body and cull them.
On 20 13, Kenichiro Lianjian published the treatment results in the international journal Oncoimmunology. After one year of HITV treatment, 62% patients achieved complete remission, 13.5% achieved partial remission, and the effective rate was as high as 75%.
The unique difference between HITV therapy and immunosuppressant is that CTL cells induced by HITV therapy, after fighting cancer cells in vivo, will transmit cancer-killing skills in vivo, and form an information transmission network through the flow of blood, making the body a highly immune environment, thus reducing the recurrence rate by improving the autoimmune ability. HITV immune cell therapy is also more flexible and can be used in conjunction with radiotherapy and chemotherapy to achieve better therapeutic effects. More than tens of thousands of people around the world have received this therapy and achieved remarkable therapeutic effects.
Zheng, an authoritative professor of gynecological oncology who is expected to become a new base for overseas therapy, added that it is impossible to treat cancer with the so-called "covering mountains and seas". HITV therapy in Lian Jian has a specialty for "solid tumors", including skin cancer, osteosarcoma, breast cancer, renal cancer, esophageal cancer, colorectal cancer, malignant lymphoma, prostate cancer, gastric cancer, bladder cancer, cervical cancer and head cancer.
According to Zheng, four generations of the family have been studying "Lian Jian HITV immune cell therapy". As early as 193 1, when people just speculated that gynecological cancer might be caused by echinococcosis, doctors in Lian Jian family pointed out that "cancer is caused by microorganisms", and later confirmed that human papillomavirus in echinococcosis was the culprit of gynecological cancer.
In the past, as many as 40% of non-Japanese patients treated in Lian Jian came from Taiwan Province Province. Zheng said that Bohui Clinic can help patients in Taiwan Province Province get treatment without going to Japan, and even attract patients from Southeast Asia to Taiwan Province Province for treatment, bringing new hope to cancer patients.